Application Note: MammaPrint and BluePrint in Early Breast Cancer: Clinical Implications of Prognostic Stratification and Molecular Subtyping
19 December 2013

This poster describes a study to compare tumor subtyping methods of clinical immunohistochemistry (IHC)/fluorescent insitu (FISH) hybridization, and MammaPrint and BluePrint and to determine which method of subtyping most accurately predicts long term outcome.